Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1953 1
1954 1
1956 1
1957 1
1967 2
1970 1
1972 3
1973 1
1974 2
1975 1
1976 4
1977 2
1980 1
1981 3
1982 5
1983 3
1984 3
1985 3
1986 4
1987 4
1988 3
1989 8
1990 2
1991 4
1992 2
1993 5
1994 1
1995 5
1996 5
1997 2
1998 1
1999 3
2000 2
2001 2
2002 4
2003 2
2004 7
2005 2
2006 5
2007 5
2008 5
2009 3
2010 6
2011 9
2012 8
2013 8
2014 7
2015 9
2016 13
2017 7
2018 12
2019 7
2020 10
2021 6
2022 14
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Results by year

Filters applied: . Clear all
Page 1
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.
Georges GE, Doney K, Storb R. Georges GE, et al. Blood Adv. 2018 Aug 14;2(15):2020-2028. doi: 10.1182/bloodadvances.2018021162. Blood Adv. 2018. PMID: 30108110 Free PMC article. Review.
At the time of diagnosis, before beginning treatment, HLA typing should be done to identify a marrow donor among family members or in the unrelated donor registries, and a marrow transplant should be considered first-line therapy. The priority order of donor …
At the time of diagnosis, before beginning treatment, HLA typing should be done to identify a marrow donor among family members or in …
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML, Carreras E, Cho B, Dandoy CE, Ho VT, Jodele S, Moissev I, Sanchez-Ortega I, Srivastava A, Atsuta Y, Carpenter P, Koreth J, Kroger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda A, Soiffer R, Vasu S. Schoettler ML, et al. Transplant Cell Ther. 2023 Mar;29(3):151-163. doi: 10.1016/j.jtct.2022.11.015. Epub 2022 Nov 25. Transplant Cell Ther. 2023. PMID: 36442770 Free PMC article.
Although some patients have a self-resolving disease, others progress to multiorgan failure and/or death. Poor prognostic features also are not uniformly accepted. ...To address this urgent need, the American Society for Transplantation and Cellular Therapy, Center …
Although some patients have a self-resolving disease, others progress to multiorgan failure and/or death. Poor prognostic features al …
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
McReynolds LJ, Rafati M, Wang Y, Ballew BJ, Kim J, Williams VV, Zhou W, Hendricks RM, Dagnall C, Freedman ND, Carter B, Strollo S, Hicks B, Zhu B, Jones K, Paczesny S, Marsh SGE, Spellman SR, He M, Wang T, Lee SJ, Savage SA, Gadalla SM. McReynolds LJ, et al. Blood. 2022 Aug 25;140(8):909-921. doi: 10.1182/blood.2022016508. Blood. 2022. PMID: 35776903 Free PMC article.
Patients with severe aplastic anemia (SAA) can have an unrecognized inherited bone marrow failure syndrome (IBMFS) because of phenotypic heterogeneity. ...The excess mortality risk in unrecognized IBMFS attributed to death from organ failure (HR …
Patients with severe aplastic anemia (SAA) can have an unrecognized inherited bone marrow failure syndrome (IBMF …
Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome.
Nelson AS, Myers KC. Nelson AS, et al. Hematol Oncol Clin North Am. 2018 Aug;32(4):687-700. doi: 10.1016/j.hoc.2018.04.006. Epub 2018 Jun 5. Hematol Oncol Clin North Am. 2018. PMID: 30047420 Review.
Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome classically associated with exocrine pancreatic dysfunction and neutropenia, with a predisposition toward progressive marrow failure, risk of myelodyspla …
Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure syndrome classically associated with …
Aplastic anemia: history and recent developments in diagnosis and treatment.
Onishi Y. Onishi Y. Int J Hematol. 2024 Mar;119(3):217-219. doi: 10.1007/s12185-024-03715-1. Epub 2024 Feb 4. Int J Hematol. 2024. PMID: 38310173
Acquired aplastic anemia is an immune-mediated disease that targets hematopoietic stem cells, which is diagnosed by findings of peripheral blood pancytopenia and hypocellular bone marrow. Although the diagnostic definition is simple, differential diagnosis from othe …
Acquired aplastic anemia is an immune-mediated disease that targets hematopoietic stem cells, which is diagnosed by findings of peripheral b …
Clinical management of aplastic anemia.
Dezern AE, Brodsky RA. Dezern AE, et al. Expert Rev Hematol. 2011 Apr;4(2):221-30. doi: 10.1586/ehm.11.11. Expert Rev Hematol. 2011. PMID: 21495931 Free PMC article. Review.
Acquired aplastic anemia is a potentially fatal bone marrow failure disorder that is characterized by pancytopenia and a hypocellular bone marrow. Hematopoietic stem-cell transplantation or bone marrow transplantation (BMT) is the …
Acquired aplastic anemia is a potentially fatal bone marrow failure disorder that is characterized by pancytopenia and …
Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic Anemia.
Metheny L, Politikos I, Ballen KK, Rezvani AR, Milano F, Barker JN, Brunstein CG; American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group. Metheny L, et al. Transplant Cell Ther. 2021 Apr;27(4):286-291. doi: 10.1016/j.jtct.2020.11.008. Transplant Cell Ther. 2021. PMID: 33836867 Free article. Review.
Bone marrow failure: pathophysiology and management.
Jacobs P. Jacobs P. Dis Mon. 1995 Apr;41(4):201-89. Dis Mon. 1995. PMID: 7698059 Review.
Although robust, it has only a limited number of responses, one of which is reduction in cellular output, sometimes with superimposed qualitative abnormalities, and this is defined as bone marrow failure. Bone marrow failure is a diverse …
Although robust, it has only a limited number of responses, one of which is reduction in cellular output, sometimes with superimposed qualit …
Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends.
Stahl M, Zeidan AM. Stahl M, et al. Expert Rev Hematol. 2017 Apr;10(4):345-364. doi: 10.1080/17474086.2017.1297704. Epub 2017 Mar 9. Expert Rev Hematol. 2017. PMID: 28277851 Review.
Myelodysplastic syndromes (MDS) are characterized by progressive bone marrow failure manifesting as blood cytopenia and a variable risk of progression into acute myeloid leukemia. ...Areas covered: We review the epidemiology, tools of risk assessment, and the …
Myelodysplastic syndromes (MDS) are characterized by progressive bone marrow failure manifesting as blood cytopenia and …
Differential diagnosis and management of anemia in the newborn.
Bizzarro MJ, Colson E, Ehrenkranz RA. Bizzarro MJ, et al. Pediatr Clin North Am. 2004 Aug;51(4):1087-107, xi. doi: 10.1016/j.pcl.2004.03.006. Pediatr Clin North Am. 2004. PMID: 15275990 Review.
Proper history taking, physical examination, and interpretation of diagnostic tests can narrow this focus and aid in establishing an accurate diagnosis and in directing the appropriate therapeutic interventions....
Proper history taking, physical examination, and interpretation of diagnostic tests can narrow this focus and aid in establishing an accurat …
239 results